Characteristics and outcomes of patients with LAM receiving sirolimus in France based on real-life data

Characteristics and outcomes of patients with LAM receiving sirolimus in France based on real-life data

LAM is a rare multi-cystic lung disease for which treatment with sirolimus is indicated in cases of moderate or severe lung disease or declining lung function. The aim of this study was to describe patients treated with sirolimus for LAM and their outcomes. This retrospective observational study was...

Full description

Saved in:
Bibliographic Details
Main Authors: Vincent Cottin, Antoine Cases, Virginie Bourdin, Martine Reynaud-Gaubert, Sandrine Hirschi, Mallorie Kerjouan, Rémi Diesler, Brieux Chardès, Stéphane Fiévez, Nada Assi, Aurélie Schmidt, Hélène Denis, Lidwine Wémeau-Stervinou, Yurdagul Uzunhan
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Medicine
Subjects:
lymphangioleiomyomatosis
lung-disease
sirolimus
rapamycin
real-life data
survival
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2024.1494713/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2024.1494713/full

Similar Items